Global Cancer Immunotherapy Market-Market Forecast, Market Trend, Market Research and Opportunity, Market Study, Size and Share – 2020-2027

Overview

Global Cancer Immunotherapy Market is expected to grow with a CAGR of xx.x% from 2020 to 2027

Immunotherapy harnesses parts of the immune system to fight cancer. It works by boosting the immune system generally, or by training the immune system to specifically target cancer cells. There are three types of immunotherapy currently in use.

The key factors that drive the development of global cancer immunotherapy market incorporate ascent in incidence and prevalence of cancer, technological advancement in treatment therapies, increment in number of R&D for the treatment of cancer, and specificity and viability of cancer immunotherapy for the treatment of extensive variety of cancers, for example, breast Cancer, melanoma cancer, head & neck cancer, colorectal cancer, lung c cancer, prostate cancer, others (Gastric, Renal Cell Carcinoma, Cervical and Lymphoma). Furthermore, the ascent in human healthcare expenditure and healthcare insurance are required to fuel the market development during the forecast period 2020-2027. However, lack of awareness and shortage of experienced and skilled professionals limit the development of global immunotherapy market.

The global cancer immunotherapy market has been segmented on the basis of technology, application, and region. On the basis of technology, the global immunotherapy market is segmented into monoclonal antibodies, Cytokines, and immunomodulators, and others. The monoclonal antibodies segment is expected to account for the largest share of the global market in 2019; also the monoclonal antibodies segment is expected to grow at the highest CAGR during the forecast period 2020-2027.

Based on application, the global cancer immunotherapy market is segmented into breast Cancer, melanoma cancer, head & neck cancer, colorectal cancer, lung cancer, prostate cancer, others (Gastric, Renal Cell Carcinoma, Cervical and Lymphoma). The lung cancer segment is expected to witness the highest CAGR from 2020 to 2027, owing to the increase incidence of this type of cancer

North America held the biggest revenue share in 2019. Rising rate of the cancer, expanding ease of access to modern therapeutics, combined with extending geriatric population, is impelling the market in the area. Then again, factors, for example, challenges in clinical trials, combined with higher expenses and quickly changing reimbursement policies, are hindering development of the global immunotherapy market in North America.

Asia Pacific is anticipated to encounter the fastest development and growing with the highest CAGR. Rising prevalence of the cancer and in turn, rising death rate is impelling interest for immunotherapy in the area. In addition, presence of market players with significant investment in the market.

New and advanced immunotherapy drugs are being introduced in China and Japan. These nations have a few progressing clinical trials and in addition approvals for new drugs molecules and combination therapies. Approvals of new treatment drugs in China and Japan are boosting the immunotherapy for treatment of cancer.

 

Market Dynamics

Drivers

  • Rise in incidence & prevalence of cancer
  • Technological advancements in treatment therapies
  • Increase in number of R&D for the treatment of cancer

Restraints

  • Lack of awareness in public.
  • Shortage of experienced healthcare professionals.

Report Key Benefits

datos-market-post-rd1

      Table of Content

  1. Market Introduction
    • Market Definition
    • Market Scope
    • Market Segments
    • Key Market Players
    • Report Key Benefits
  2. Research Methodology
    • Research Process
    • Market Estimations and Trend Analysis
    • Executive Summary
  3. Market Dynamics
    • Market Share Analysis
    • Porter’s Five Forces
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Global Cancer Immunotherapy Market by Type
    • Market Overview, by Type
    •  Cancer Vaccines
      • Overview
      • Market Share, 2019
      • Market Size and Forecast
    •  Checkpoint Inhibitors
      • Overview
      • Market Share, 2019
      • Market Size and Forecast
      • Abdominal Aortic Aneurysm (AAA)
        • Overview
        • Market Share, 2019
        • Market Size and Forecast
      •  Immunomodulators
        • Overview
        • Market Share, 2019
        • Market Size and Forecast
      •  Monoclonal Antibodies
        • Overview
        • Market Share, 2019
        • Market Size and Forecast
  5. Global Cancer Immunotherapy Market by Application
    • Market Overview, by Application
    •  Melanoma
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    • Prostate Cancer
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    • Breast Cancer
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    •  Lung Cancer
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    • Head and Neck Cancer
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    • Colorectal Cancer
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    • Others
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
  6. Global Cancer Immunotherapy Market by End User
    • Market Overview, by End User
    •  Hospitals
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
    •  Clinics & Others
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
  7. Global Cancer Immunotherapy Market by Geography
    • Market Overview by Geography
    • North America
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
      • US.
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Canada
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Mexico
        • Overview
        • Market Share, 2019
        • Market Size , 2020-2027
    •  Europe
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
      • Germany
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • United Kingdom
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • France
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Spain
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Italy
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Rest of Europe
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
    •  Asia-Pacific
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
      • Japan
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • China
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • India
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Australia
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • South Korea
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Rest of Asia-Pacific
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
    •  Rest Of World
      • Overview
      • Market Share, 2019
      • Market Size, 2020-2027
      • Brazil
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Argentina
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • South Africa
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Middle East
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
      • Others
        • Overview
        • Market Share, 2019
        • Market Size, 2020-2027
  8. Company profiles
    •  Bristol-Myers Squibb Company (U.S.)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    •  Seattle Genetics Inc. (U.S.)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Merck & Co., Inc. (U.S.)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    •  Celgene Corporation (U.S.)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    •  Amgen Inc. (U.S.)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    •  Eli Lilly and Company (U.S.)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • MAQUET Holding B.V. & Co. KG
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    •   Hoffmann-La Roche Ltd (Switzerland)
      • Overview
      • Financials
      • Business Segments
      • Recent Developments

Market Segments

By Type

  • Cancer Vaccines
  • Checkpoint Inhibitors
  • Immunomodulators
  • Monoclonal Antibodies

By Application

  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Others

By End User

  • Hospitals
  • Clinics & Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest Of The World
    • Brazil
    • Argentina
    • South Africa
    • Middle East
    • Rest of The World

 Company Profiles

  • Bristol-Myers Squibb Company (U.S.)
  • Seattle Genetics Inc. (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Celgene Corporation (U.S.)
  • Amgen Inc. (U.S.)
  • Eli Lilly and Company (U.S.)
  • Hoffmann-La Roche Ltd (Switzerland)

Target Audience

  • Service providers, dealers, distributors, and suppliers in Cancer Immunotherapy..
  • Healthcare institutes
  • Research institutes, associations and academicians
  • Market research and consulting firms
Place an Order

Testimonial

Looking for a Market Analysis Report?